Maternal Vascular Malperfusion and Anatomic Cord Abnormalities Are Prevalent in Pregnancies With Fetal Congenital Heart Disease
Prenatal Diagnosis · 2025-09 · 45 (10) · 1325-1333
DOI: 10.1002/pd.6650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, online erschienen am 30.08.2024. Verfasst von Chrystalle Katte Carreon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Heart Defects, Congenital, Placenta, Umbilical Cord, Placenta Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: NICHD NIH HHS, American Heart Association Career Development, NIH HHS.
Abstract (Originalsprache)
Objective
Impairments in the maternal‐fetal environment are associated with adverse postnatal outcomes among infants with congenital heart disease. Therefore, we sought to investigate placental anomalies as they related to various forms of fetal congenital heart disease (FCHD).
Methods
We reviewed the placental pathology in singleton pregnancies with and without FCHD. FCHD was divided into separate categories (transposition physiology, obstructive left, obstructive right, biventricular without obstruction, and others). Exclusion criteria included other prenatally known structural malformations and/or aneuploidy. The significance threshold was set at p < 0.05 or False Discovery rate q < 0.05 when multiple tests were performed.
Results
The cohort included 215 FCHD and 122 non‐FCHD placentas. FCHD placentas showed increased rates of maternal vascular malperfusion (24% vs. 5%, q < 0.001) and cord anomalies (27% vs. 1%, q < 0.001). Placentas with fetal TGA demonstrated a lower rate of hypoplasia when compared with other FCHD types (1/39 vs. 51/176, Fisher's exact p = 0.015).
Conclusion
Placental maternal vascular malperfusion is increased in FCHD. The prevalence of vascular malperfusion did not differ by FCHD type, indicating that CHD type does not predict the likelihood of placental vascular dysfunction. Further investigation of the placental‐fetal heart axis in FCHD is warranted given the importance of placental health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA.
- Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.
- Division of Newborn Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
- Department of Pediatric Cardiology and Pediatric Intensive Care, Ludwig Maximilian University, Munich, Germany.
ORCID-Profile: Christina Ronai, Sarah U Morton
Förderung
- NICHD NIH HHS
- American Heart Association Career Development
- NIH HHS
- American Heart Association
- National Institutes of Health
Zitieren
APA
Carreon, C. K., Ronai, C., Hoffmann, J. K., Tworetzky, W., Morton, S. U., & Wilkins-Haug, L. E. (2025). Maternal Vascular Malperfusion and Anatomic Cord Abnormalities Are Prevalent in Pregnancies With Fetal Congenital Heart Disease. Prenatal Diagnosis, 45(10), 1325-1333. https://doi.org/10.1002/pd.6650
Vancouver
Carreon CK, Ronai C, Hoffmann JK, Tworetzky W, Morton SU, Wilkins-Haug LE. Maternal Vascular Malperfusion and Anatomic Cord Abnormalities Are Prevalent in Pregnancies With Fetal Congenital Heart Disease. Prenatal Diagnosis. 2025;45(10):1325-1333. doi:10.1002/pd.6650
BibTeX
@article{Carreon2025,
author = {Carreon, Chrystalle Katte and Ronai, Christina and Hoffmann, Julia K and Tworetzky, Wayne and Morton, Sarah U and Wilkins-Haug, Louise E},
title = {Maternal Vascular Malperfusion and Anatomic Cord Abnormalities Are Prevalent in Pregnancies With Fetal Congenital Heart Disease},
journal = {Prenatal Diagnosis},
year = {2025},
volume = {45},
number = {10},
pages = {1325--1333},
doi = {10.1002/pd.6650}
}
EUVIMED